All news articles for December 2018

(Image: Getty/Sarinyapinngam)

Guest Column

Collaboration created the cornerstone of better clinical trials – now, it’s time to build

By Pamela Tenaerts, executive director, Clinical Trials Transformation Initiative (CTTI)

We entered 2018 with a solid foundation in place for building better, more efficient clinical trials. Throughout the year, progress – particularly in the areas of mobile technologies, real-world evidence, and patient engagement – resulted in new, tangible...

(Image: Getty/kritchanut)

Guest column

M&A in the CRO industry: The Good, The Bad, and The Ugly

By Matthew Barrows, senior business consultant

M&A is a huge part of the CRO space. Inorganic growth has long been the go-to strategy for any CRO and we’re never surprised to see this month’s latest deal. However, I’d like to challenge the idea that this is always the best way to grow a CRO business.

(Image: Getty/masterzphotois)

The biggest paradigm shift in decades? ICH E6 R2

By Melissa Fassbender

ICH E6 R2 sparked a paradigm shift, though 2019 will see the clinical trials industry transition from a risk-based monitoring approach to risk-based quality management.

(Image: Getty/	Burak Karademir)

2019: The year of women in research?

By Maggie Lynch

It’s been 25 years since the NIH Revitalization Act, yet, the industry is only now approaching parity in clinical research, says researcher.

Follow us

Products

View more

Webinars